CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE: 1,828 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
1,828
Total FAERS Reports
222 (12.1%)
Deaths Reported
935
Hospitalizations
1,828
As Primary/Secondary Suspect
239
Life-Threatening
62
Disabilities
First Report: 19820101 · Latest Report: 20250810
What Are the Most Common CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE Side Effects?
#1 Most Reported
Dyspnoea
211 reports (11.5%)
#2 Most Reported
Dizziness
191 reports (10.4%)
#3 Most Reported
Condition aggravated
186 reports (10.2%)
All CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 211 | 11.5% | 46 | 138 |
| Dizziness | 191 | 10.5% | 13 | 97 |
| Condition aggravated | 186 | 10.2% | 47 | 111 |
| Hyponatraemia | 173 | 9.5% | 3 | 153 |
| Asthma | 153 | 8.4% | 46 | 84 |
| Therapeutic product effect incomplete | 150 | 8.2% | 46 | 84 |
| Anxiety | 149 | 8.2% | 46 | 98 |
| Vasculitis | 136 | 7.4% | 46 | 93 |
| Acute kidney injury | 135 | 7.4% | 26 | 91 |
| Lung disorder | 127 | 7.0% | 46 | 84 |
| Obstructive airways disorder | 127 | 7.0% | 46 | 83 |
| Pulmonary fibrosis | 127 | 7.0% | 46 | 83 |
| Pulmonary vasculitis | 127 | 7.0% | 47 | 84 |
| Wheezing | 127 | 7.0% | 45 | 83 |
| Haemoptysis | 126 | 6.9% | 46 | 83 |
| Neuritis | 126 | 6.9% | 46 | 83 |
| Neurological symptom | 126 | 6.9% | 46 | 83 |
| Pulmonary alveolar haemorrhage | 126 | 6.9% | 46 | 83 |
| Respiratory symptom | 126 | 6.9% | 46 | 83 |
| Hypothyroidism | 125 | 6.8% | 46 | 83 |
Who Reports CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE Side Effects? Age & Gender Data
Gender: 51.5% female, 48.5% male. Average age: 68.2 years. Most reports from: CA. View detailed demographics →
Is CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 7 | 0 | 5 |
| 2005 | 6 | 0 | 2 |
| 2006 | 2 | 0 | 1 |
| 2007 | 15 | 0 | 10 |
| 2008 | 9 | 0 | 6 |
| 2009 | 6 | 0 | 2 |
| 2010 | 12 | 1 | 7 |
| 2011 | 11 | 0 | 7 |
| 2012 | 27 | 0 | 15 |
| 2013 | 27 | 1 | 19 |
| 2014 | 103 | 5 | 61 |
| 2015 | 85 | 10 | 48 |
| 2016 | 95 | 8 | 56 |
| 2017 | 148 | 14 | 83 |
| 2018 | 156 | 3 | 77 |
| 2019 | 77 | 2 | 35 |
| 2020 | 87 | 12 | 31 |
| 2021 | 57 | 2 | 31 |
| 2022 | 37 | 13 | 20 |
| 2023 | 34 | 0 | 16 |
| 2024 | 60 | 26 | 30 |
| 2025 | 20 | 3 | 15 |
What Is CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE Used For?
| Indication | Reports |
|---|---|
| Hypertension | 753 |
| Product used for unknown indication | 718 |
| Blood pressure abnormal | 45 |
| Essential hypertension | 13 |
| Suicide attempt | 12 |
| Arrhythmia | 6 |
| Atrial fibrillation | 6 |
| Blood pressure measurement | 6 |
| Cardiovascular disorder | 6 |
| Blood pressure increased | 5 |
CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE vs Alternatives: Which Is Safer?
CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE vs CANGRELOR
CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE vs CANIS LUPUS FAMILIARIS SKIN
CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE vs CANNABIDIOL
CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE vs CANNABIDIOL\HERBALS
CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE vs CANNABIS SATIVA FLOWERING TOP
CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE vs CANNABIS SATIVA SUBSP. INDICA TOP
CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE vs CANRENOATE
CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE vs CANRENOIC ACID
CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE vs CANRENONE
CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE vs CANTHARIDIN
Official FDA Label for CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
Official prescribing information from the FDA-approved drug label.